Characterization of NKR+ T-cell subsets in human bone marrow:: implications for immunosurveillance of neoplasia

被引:10
作者
Dean, J
McCarthy, D
Lawler, M
Doherty, DG
O'Farrelly, C
Golden-Mason, L [1 ]
机构
[1] St Vincents Hosp, Educ & Res Ctr, Dublin 4, Ireland
[2] St Vincents Hosp, Dept Haematol, Dublin 4, Ireland
[3] St James Hosp, Natl Ctr Bone Marrow Transplant, Dublin 8, Ireland
[4] Inst Immunol, Maynooth, Kildare, Ireland
[5] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland
关键词
bone marrow; immunosurveillance; neoplasia;
D O I
10.1016/j.clim.2004.08.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to hematopoietic progenitors, human bone marrow contains mature T/NK lymphocytes. Valpha24Vbeta11 NKT-cells, a subset of NK receptor(+) (NKR+) T-cells in humans, are rare in bone marrow, suggesting the presence of other NKR+ T-cells which may contribute to tumor surveillance. NKR+/- T-cells were examined in blood (PB), and bone marrow from donors (DM) and patients with active hematopoietic malignancy (PM), or in remission (PR). T-cells in PR & PM were enriched for CD56(+) and CD57(+) subsets, compared to DM. All marrow NKR+/- T-cell subsets were more activated than PB. PM and, Surprisingly, PR marrow contained more activated cells than DM. CD8(+) cells were significantly increased in all patient marrows and there was evidence of the formation of all effector/memory pool in malignant marrow. These data suggest that NKR+ T-cell enrichment in human bone marrow that has been exposed to neoplastic transformation is compatible with a role in localized tumor surveillance/eradication. (C) 2004 Published by Elsevier Inc.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 49 条
[1]   NK1.1+ CD4+ CD8- THYMOCYTES WITH SPECIFIC LYMPHOKINE SECRETION [J].
ARASE, H ;
ARASE, N ;
NAKAGAWA, K ;
GOOD, RA ;
ONOE, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (01) :307-310
[2]   MOUSE CD1 IS DISTINCT FROM AND COEXISTS WITH TL IN THE SAME THYMUS [J].
BRADBURY, A ;
BELT, KT ;
NERI, TM ;
MILSTEIN, C ;
CALABI, F .
EMBO JOURNAL, 1988, 7 (10) :3081-3086
[3]   CD1: Antigen presentation and T cell function [J].
Brigl, M ;
Brenner, MB .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :817-890
[4]  
Brittenden J, 1996, CANCER-AM CANCER SOC, V77, P1226, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO
[5]  
2-G
[6]   2 CLASSES OF CD1 GENES [J].
CALABI, F ;
JARVIS, JM ;
MARTIN, L ;
MILSTEIN, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (02) :285-292
[7]   CCR7 expression and memory T cell diversity in humans [J].
Campbell, JJ ;
Murphy, KE ;
Kunkel, EJ ;
Brightling, CE ;
Soler, D ;
Shen, ZM ;
Boisvert, J ;
Greenberg, HB ;
Vierra, MA ;
Goodman, SB ;
Genovese, MC ;
Wardlaw, AJ ;
Butcher, EC ;
Wu, LJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :877-884
[8]  
CLARK P, 1986, BLOOD, V67, P1600
[9]   Requirement for V(alpha)14 NKT cells in IL-12-mediated rejection of tumors [J].
Cui, JQ ;
Shin, T ;
Kawano, T ;
Sato, H ;
Kondo, E ;
Toura, I ;
Kaneko, Y ;
Koseki, H ;
Kanno, M ;
Taniguchi, M .
SCIENCE, 1997, 278 (5343) :1623-1626
[10]   Natural killer 1.1+ αβ T cells in the periimplantation uterus [J].
Dang, Y ;
Beckers, J ;
Wang, CR ;
Heyborne, KD .
IMMUNOLOGY, 2000, 101 (04) :484-491